Skip to Content

Kuvan Side Effects

Generic Name: sapropterin

Note: This document contains side effect information about sapropterin. Some of the dosage forms listed on this page may not apply to the brand name Kuvan.

In Summary

Common side effects of Kuvan include: headache and rhinorrhea. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to sapropterin: oral powder for solution, oral tablet disintegrating

Along with its needed effects, sapropterin (the active ingredient contained in Kuvan) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking sapropterin:

More common

  • Fever

Incidence not known

  • Burning feeling in the chest or stomach
  • cough
  • difficulty with swallowing
  • dizziness
  • fast heartbeat
  • fidgeting or moving around too much
  • indigestion
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • skin rash, hives, or itching
  • stomach upset
  • talking too much
  • tenderness in the stomach area
  • tightness in the chest
  • unusual tiredness or weakness

Some side effects of sapropterin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

  • Stuffy nose

For Healthcare Professionals

Applies to sapropterin: oral powder for reconstitution, oral tablet dispersible

General

In phenylketonuria (PKU) trials, the most common side effects were headache, rhinorrhea, pharyngolaryngeal pain, diarrhea, vomiting, cough, and nasal congestion.

In clinical trials for non-PKU indications, a different formulation was used in patients with disorders other than PKU; some had underlying neurologic disorders or cardiovascular disease. Common side effects were headache, peripheral edema, arthralgia, polyuria, agitation, dizziness, nausea, pharyngitis, abdominal pain, upper abdominal pain, and upper respiratory tract infection. Serious and severe side effects included convulsions, exacerbation of convulsions, dizziness, gastrointestinal bleeding, postprocedural bleeding, headache, irritability, myocardial infarction, overstimulation, and respiratory failure.[Ref]

Nervous system

Very common (10% or more): Headache (15%)
Common (1% to 10%): Dizziness
Frequency not reported: Convulsions, exacerbation of convulsions, overstimulation
Postmarketing reports: Hyperactivity[Ref]

Respiratory

Very common (10% or more): Rhinorrhea (11%), pharyngolaryngeal pain (10%)
Common (1% to 10%): Cough, nasal congestion, pharyngitis, upper respiratory tract infection
Frequency not reported: Respiratory failure
Postmarketing reports: Pharyngitis[Ref]

Metabolic

Very common (10% or more): Low phenylalanine levels
Common (1% to 10%): Hypophenylalaninemia[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, vomiting, nausea, abdominal pain, upper abdominal pain
Frequency not reported: Gastrointestinal bleeding
Postmarketing reports: Oropharyngeal pain, esophageal pain, gastritis, dyspepsia, abdominal pain, nausea, vomiting[Ref]

Cardiovascular

Frequency not reported: Myocardial infarction[Ref]

Other

Common (1% to 10%): Peripheral edema
Frequency not reported: Contusion, postprocedural bleeding, pyrexia[Ref]

Psychiatric

Common (1% to 10%): Agitation
Frequency not reported: Irritability

Musculoskeletal

Common (1% to 10%): Arthralgia[Ref]

Genitourinary

Common (1% to 10%): Polyuria[Ref]

Hypersensitivity

Postmarketing reports: Hypersensitivity reactions (including serious allergic reactions, anaphylaxis, rash)[Ref]

Dermatologic

Frequency not reported: Rash[Ref]

Hepatic

Frequency not reported: Increased GGT[Ref]

References

1. "Product Information. Kuvan (sapropterin)." BioMarin Pharmaceutical Inc, Novato, CA.

2. Cerner Multum, Inc. "Australian Product Information." O 0

3. Dubois EA, Cohen AF "Sapropterin." Br J Clin Pharmacol 69 (2010): 576-7

4. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide